Prescription of phototherapy in psoriasis;Prescrire une photothérapie dans le psoriasis

Revue du Praticien

Volumn 54, Issue 1, 2004, Pages 43-47

  Beani, Jean Claude ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BERGAPTEN; CYCLOSPORIN; METHOTREXATE; METHOXSALEN; PSORALEN; RETINOID;

CANCER RISK; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; LONG TERM CARE; PHOTOTHERAPY; PSORIASIS; PUVA; REVIEW; RISK BENEFIT ANALYSIS; SKIN CANCER; SKIN IRRITATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ACUTE DISEASE; COMBINED MODALITY THERAPY; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; PSORALENS; PSORIASIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

EID: 1542269153     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974; 291:1207-11.
2. Beani JC. Photothérapie UVB et puvathérapie. In: Dubertret L (ed.). Thérapeutique dermatologique. Paris: Medecines-Sciences Flammarion, 2001; 1137-54.
3. Jeanmougin M. Photothérapie et photochimiothérapie par ultraviolets. Encycl Med Chir (Elsevier, Paris). Dermatologie, 1999, 98-930-A-10.
4. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-62.
5. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of psoriasis with a 311 nm UVB lamp. Br J Dermatol 1992; 127: 509-12.
6. Wolf K. Side effects of psoralen photochemotherapy. Br J Dermatol 1990; 12:117-25.
7. Drake LA, Ceilly RI, Cornelison et al. Guidelines of care for phototherapy and photochemotherapy. J Am Acad Dermatol 1994; 31: 643-8.
8. Norris PG. British photodermatology Group. Guidelines for PUVA. Br J Dermatol 1994; 130: 246-55.
9. Stern RS, Valeva ZH and members of the photochemotherapy follow-up study. Non cutaneous malignant tumors in the PUVA follow-up study. J Invest Dermatol 1997; 108: 897-900.
10. Stern RS, Bagheri S, Nichols K. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A for psoriasis. J Am Acad Dermatol 2002; 47: 33-9.
11. Stern RS, Nichols KT, Wakeva LH. Malignant melanoma in patients treated for psoriasis with methoxalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997; 336: 1041-5.
12. Pasher-de Jong P, Wielink G, van der Valk PGM, van der Wilt GJ. Treatment with UV-B for psoriasis and nonmelanoma skin cancer. A systematic review of the literature. Arch Dermatol 1999; 135: 834-40.
13. Frappaz A, Thivolet J. Calcipotriol in combination with puva: a randomized double-blind placebo study in severe psoriasis. Eur J Dermatol 1993; 3: 351-4.
14. Roenigk H.H. Jr. Acitretin combination therapy. J Am Acad Dermatol 1999; 41: S18-S21.
15. Lebwohl M. Acitretin in combination with UVB or PUVA. J Am Acad Dermatol 1999; 41: s22-s24.
16. Gerritsen MJ, Boezeman JB, Elbers ME, van de Kerkhof PC. Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): a new approach in the treatment of psoriasis. Skin pharmacol. Appl Skin Physiol 1998; 11:133-9.
17. Molin L. Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB study group. Dermatology 1999; 198: 375-81.
18. Hecker D, Worsley J, Yueh G, Kuroda K, Lebwohl M. Interactions between tazarotene and ultraviolet light. J Am Acad Dermatol 1999; 41: 927-30.
19. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis. Arch Dermatol 1999; 135: 519-24.
20. Stern RS, Lange R. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxalen photochemotherapy (PUVA) for the treatment of psoriasis. Arch Dermatol 1991; 127: 347-50.